the article is about some medicine company's shares going up. this is because they found out that their medicine can help people who are in pain. they did some tests with rats and it worked. because of this, people who buy and sell shares of the company are happy and they want to buy more shares, so the price goes up. Read from source...

"Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket" by Avi Kapoor, Benzinga Staff Writer on August 26, 2024.

- The article title suggests that MIRA Pharmaceuticals shares are trading higher due to a breakthrough achieved by the company, but the content does not explain clearly or comprehensively the reasons for this trading.
- It states that MIRA Pharmaceuticals achieved 100% reversal of neuropathic pain with oral Ketamin-2 in a rat study, but it doesn't provide sufficient information about the study, its methodology, or the significance of the results.
- The article moves hastily from the focus on MIRA Pharmaceuticals to listing twenty other stocks moving in the pre-market trading, with no clear connection or justification for this shift.
- The gains and losses mentioned for the other stocks are presented without any context or explanation, leaving readers uninformed about why these stocks are moving.
- The article lacks critical assessment and fails to analyze the implications of the stock movements for investors or the broader market.

Overall, the article's writing style is casual, and its content is superficial, lacking depth, and not providing valuable insights for its readers.

1. MIRA Pharmaceuticals Inc (MIRA): MIRA Pharmaceuticals shares are trading higher by around 45%. This is due to the company announcing it achieved 100% reversal of neuropathic pain with oral Ketamin-2 in a rat study. The risks include that it's a rat study and the success might not translate to human trials.

2. Med rom Healthcare Technologies Inc (MRM): MRM gained 135.5% to $5.84 in pre-market trading after Med rom Mother Labs partnered with NFES Technologies in a capital and business alliance. The risks include that it's a pre-market trading gain and the success might not be realized in actual market trading.

3. Prestige Wealth Inc (PWM): PWM rose 57% to $1.17 in today's pre-market trading after the company announced that it entered into a definitive acquisition agreement to purchase all shares of SPW Global. The risks include that it's a pre-market trading gain and the success might not be realized in actual market trading.

4. Top KingWin Ltd (TCJH): TCJH gained 45.6% to $0.33 in pre-market trading after gaining 13% on Friday. The risks include that it's a pre-market trading gain and the success might not be realized in actual market trading.

5. Tevogen Bio Holdings Inc (TVGN): TVGN gained 32.8% to $0.77 in pre-market trading. Tevogen Bio, last week, secured $6 million Series C Preferred stock investment with The Patel Family, LLP. The risks include that it's a pre-market trading gain and the success might not be realized in actual market trading.

6. Perfect Moment Ltd (PMNT): PMNT gained 28.8% to $1.34 in pre-market trading after declining 7% on Friday. The risks include that it's a pre-market trading gain and the success might not be realized in actual market trading.

7. Scisparc Ltd (SPRC): SPRC gained 19.1% to $0.44 in pre-market trading after the company submitted an Investigational New Drug (IND) application to the FDA for SCI-110. The risks include that it's a pre-market trading gain and the success might not be realized in actual market trading.

8. Santech Holdings Ltd - ADR (STEC): STEC gained 8.3% to $0.42 in pre-market trading after announcing a $5 million share repurchase program. The risks include that it's a pre-market trading gain and the success might not be realized in actual market trading.

9. Galapagos NV - ADR (GLPG): GLPG climbed 8.3% to $28.07 in pre-market trading. On Friday, Galapagos announced the FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T,